We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to Premade lentiviral particles
  • Whole-cell labeling
  • Organelle labeling
  • Tet-On 3G transactivator
Selection guides Virus kits: product finder tool
Learn about lentiviral transduction experiments Lentivirus learning center
Home › Products › Gene function › Viral transduction › Lentivirus › Premade lentiviral particles › Organelle labeling

Lentivirus

  • Vector systems
    • Constitutive promoter
    • EF-1 alpha promoter
    • IRES bicistronic
    • Fluorescent protein
    • Tet-inducible
  • Premade lentiviral particles
    • Whole-cell labeling
    • Organelle labeling
    • Tet-On 3G transactivator
  • Packaging systems and cells
    • Lenti-X packaging single shots
    • Lenti-X 293T cells
  • Titration kits
    • Lenti-X GoStix Plus
    • qRT-PCR
    • p24 ELISA
    • Integrated copy number
  • Transduction sponges
    • Lenti-X Transduction Sponge
    • Lenti-X T-Cell Transduction Sponge
  • Transduction enhancers
    • Lenti-X Accelerator
    • Ecotropic Receptor Booster
Need help?
Contact Sales
Selection guides Virus kits: product finder tool
Learn about lentiviral transduction experiments Lentivirus learning center

Lentiviral particles for fluorescent labeling of specific subcellular structures

Labeling of mitochondria, golgi, nucleus, membrane, ER and other subcellular structures

These premade, highly concentrated and purified lentiviral particles deliver sequences that express fluorescent protein tags (AcGFP1 or mCherry) targeted to specific subcellular locations. Particles are available for visualization of the nucleus, endoplasmic reticulum, mitochondria, endosomes, golgi, cytoskeleton, and plasma membrane

These premade, highly concentrated and purified lentiviral particles deliver sequences that express fluorescent protein tags (AcGFP1 or mCherry) targeted to specific subcellular locations. Particles are available for visualization of the nucleus, endoplasmic reticulum, mitochondria, endosomes, golgi, cytoskeleton, and plasma membrane. Transduction allows direct visualization of specific organelles or structures, creating reporter cells that are useful for investigating protein localization, protein dynamics, and protein trafficking.

The fluorescent markers offered (AcGFP1 and mCherry) allow for multicolor labeling and direct detection by fluorescence microscopy.

 More  Less
Cat. # Product Size Price License Quantity Details
0013VCT rLV.EF1.AcGFP1-Actin-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Actin-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Various cell types can be transduced with Vectalys lentiviral particles, including primary and stem cell lines

Various cell types can be transduced with Vectalys lentiviral particles, including primary and stem cell lines
Various cell types can be transduced with Vectalys lentiviral particles, including primary and stem cell lines. The suggested seeding concentration and MOI vary depending on the specific cell type to be transduced. When the recommendations in this table are followed, transduction efficiency is high for immortalized, primary, and stem cells, regardless of whether they are adherent or suspension cells.

Back

Overview of the process for generating high-titer lentiviral particles

Overview of the process for generating high-titer lentiviral particles
Overview of the process for generating high-titer lentiviral particles. Through this proprietary, large-scale process Vectalys is able to produce very high-titer, high-purity lentiviruses ready for transduction of many different cell types. The high titer allows for manipulation of even hard-to-transduce cells, like primary cells or stem cells, and the exceptional purity prevents cytotoxicity.

Back

Comparison of the purity of lentiviruses generated with Vectalys’ method or a classic purification method

Comparison of the purity of lentiviruses generated with Vectalys’ method or a classic purification method
Comparison of the purity of lentiviruses generated with Vectalys’ method or a classic purification method. Lentiviral proteins were separated by SDS-PAGE and stained with Coomassie Blue. The high purity of Vectalys lentiviral particles is clear when comparing the two methods; even when Vectalys particles are loaded at a 10-fold higher amount, very little contaminating protein is seen. The ratio of total particles (physical particles) to functional particles (transducing units) is lower for Vectalys purified lentivirus compared to classic methods of purification, indicating higher purity. Data provided by Vectalys.

Back

What is a functional titer? Most vendors of ready-made viral particles determine their titers using a simple particle count

What is a functional titer? Most vendors of ready-made viral particles determine their titers using a simple particle count

What is a functional titer? Most vendors of ready-made viral particles determine their titers using a simple particle count. This count will include free capsid protein, nonfunctional and immature virions, as well as functional virus.The functional titer provided by Clontech and Vectalys is not just the total particle number, it is a measurement of the total number of virions capable of integrating into cells, measured by transducing HCT116 cells. In real terms, this means our viral preps contain up to 100-fold more infectious particles than preps from other vendors.

Back

Achieve 100% transduction efficiency even in cell types that are typically hard to infect

Achieve 100% transduction efficiency even in cell types that are typically hard to infect
Achieve 100% transduction efficiency even in cell types that are typically hard to infect. Super-concentrated highly purified lentivirus prepared by Vectalys permits transduction at high M.O.I.

Back

0013VCT: rLV.EF1.AcGFP1-Actin-9

0013VCT: rLV.EF1.AcGFP1-Actin-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

Back

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively.

Back

Not all titers are the same! Comparison of cells transduced with 100 M

Not all titers are the same! Comparison of cells transduced with 100 M

Not all titers are the same! Comparison of cells transduced with 100 M.O.I. of lentivirus provided by Clontech/Vectalys versus 100 M.O.I. of lentivirus provided by Vendor S. Each premade virus preparation expresses a green fluorescent protein when transduced. Clontech/Vectalys provides a functional titer, so every cell treated with our virus preparation was transduced with multiple copies of virus, leading to strong expression of the fluorescent protein. By contrast, the titer provided by Vendor S includes nonfunctional lentivirus particles as a large percentage of the titer so 100 M.O.I of their virus preparation is not sufficient to effectively transduce the cells.

0014VCT rLV.EF1.AcGFP1-Tubulin-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Tubulin-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

0014VCT: rLV.EF1.AcGFP1-Tubulin-9

0014VCT: rLV.EF1.AcGFP1-Tubulin-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

Back

Fluorescent labelling of tubulin in mammalian cells

Fluorescent labelling of tubulin in mammalian cells
Fluorescent labelling of tubulin in mammalian cells. HeLa cells were infected at 80 M.O.I. with ready-made lentivirus engineered to expressed AcGFP1-Tubulin (Right image; Cat. No. 0014VCT) or mCherry Tubulin (Left image; Cat. No. 0021VCT).
0015VCT rLV.EF1.AcGFP1-Golgi-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Golgi-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

The golgi apparatus of HCT116 cells visualized using recombinant lentivirus (Cat. No. 0015 VCT rLV.EF1.AcGFP1-Golgi-9) expressing AcGFP1 fluorescent protein fused to the N-terminal 81 amino acids of human β 1,4-galactosyltransferase, which contains a membrane-anchoring signal peptide

The golgi apparatus of HCT116 cells visualized using recombinant lentivirus (Cat. No. 0015 VCT rLV.EF1.AcGFP1-Golgi-9) expressing AcGFP1 fluorescent protein fused to the N-terminal 81 amino acids of human β 1,4-galactosyltransferase, which contains a membrane-anchoring signal peptide
The golgi apparatus of HCT116 cells visualized using recombinant lentivirus (Cat. No. 0015 VCT rLV.EF1.AcGFP1-Golgi-9) expressing AcGFP1 fluorescent protein fused to the N-terminal 81 amino acids of human β 1,4-galactosyltransferase, which contains a membrane-anchoring signal peptide.

Back

0015VCT: rLV.EF1.AcGFP1-Golgi-9

0015VCT: rLV.EF1.AcGFP1-Golgi-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

0016VCT rLV.EF1.AcGFP1-Nuc-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Nuc-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

0016VCT: rLV.EF1.AcGFP1-Nuc-9

0016VCT: rLV.EF1.AcGFP1-Nuc-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

Back

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively)

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively)

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively).

0017VCT rLV.EF1.AcGFP1-Mito-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Mito-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

0017VCT: rLV.EF1.AcGFP1-Mito-9

0017VCT: rLV.EF1.AcGFP1-Mito-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

Back

Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins

Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins
Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins. HCT116 cells and Hela cells were transduced using Cat. Nos. 0024VCT and 0017VCT respectively. The lentivirus vectors express a fusion protein consisting of a fluorescent protein tagged with the targeting sequence from subunit VIII of cytochrome c oxidase that targets mitochondria.
0018VCT rLV.EF1.AcGFP1-Endo-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Endo-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Endosome labeling using concentrated and purified lentivirus

Endosome labeling using concentrated and purified lentivirus
Endosome labeling using concentrated and purified lentivirus. HeLa cells were transduced using rLV.EF1.AcGFP1-Endo-9 (Cat. No 0018VCT) at an M.O.I of 80. The ready-made lentivirus encodes a fusion of RhoB GTPase and AcGFP1 which, when expressed, localizes to the surface of vesicles of the endocytic pathway.

Back

0018VCT: rLV.EF1.AcGFP1-Endo-9

0018VCT: rLV.EF1.AcGFP1-Endo-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

0019VCT rLV.EF1.AcGFP1-Mem-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
39 AcGFP is covered by U.S. Patent Numbers; 7,432,053, 7,667,016, 7,879,988 and 7,897,726.
72 Living Colors Fluorescent Protein Products: Not-For-Profit Entities: Orders may be placed in the normal manner by contacting your local representative or Takara Bio USA, Inc. Customer Service. Any and all uses of this product will be subject to the terms and conditions of the Non-Commercial Use License Agreement (the “Non-Commercial License”), a copy of which can be found below. As a condition of sale of this product to you, and prior to using this product, you must agree to the terms and conditions of the Non-Commercial License. Under the Non-Commercial License, Takara Bio USA, Inc. grants Not-For-Profit Entities a non-exclusive, non-transferable, non-sublicensable and limited license to use this product for internal, non-commercial scientific research use only. Such license specifically excludes the right to sell or otherwise transfer this product, its components or derivatives thereof to third parties. No modifications to the product may be made without express written permission from Takara Bio USA, Inc. Any other use of this product requires a different license from Takara Bio USA, Inc. For license information, please contact a licensing representative by phone at 650.919.7320 or by e-mail at licensing@takarabio.com. For-Profit Entities wishing to use this product are required to obtain a license from Takara Bio USA, Inc. For license information, please contact a licensing representative by e-mail at licensing@takarabio.com. Not-For-Profit Non-Commercial Use License: A copy of the rLV.EF1.AcGFP1-Mem-9 product License Agreement can be found by clicking here.
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with AcGFP1 fluorescent protein.

Back

0019VCT: rLV.EF1.AcGFP1-Mem-9

0019VCT: rLV.EF1.AcGFP1-Mem-9

Back

Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane

Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane
Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane. (Cat. # 0019VCT and 0026VCT, respectively.) The blue channel in the right image is DAPI staining of the nucleus.
0020VCT rLV.EF1.mCherry-Actin-9 3 x 20 uL USD $2325.00

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively

Subcellular staining of actin using recombinant lentivirus to deliver and express fusions of actin to mCherry (Cat. # 0020VCT rLV.EF1.mCherry-Actin-9) and AcGFP1 (Cat. # 0013VCT rLV.EF1.AcGFP1-Actin-9), respectively.

Back

Not all titers are the same! Comparison of cells transduced with 100 M

Not all titers are the same! Comparison of cells transduced with 100 M

Not all titers are the same! Comparison of cells transduced with 100 M.O.I. of lentivirus provided by Clontech/Vectalys versus 100 M.O.I. of lentivirus provided by Vendor S. Each premade virus preparation expresses a green fluorescent protein when transduced. Clontech/Vectalys provides a functional titer, so every cell treated with our virus preparation was transduced with multiple copies of virus, leading to strong expression of the fluorescent protein. By contrast, the titer provided by Vendor S includes nonfunctional lentivirus particles as a large percentage of the titer so 100 M.O.I of their virus preparation is not sufficient to effectively transduce the cells.

Back

0020VCT: rLV.EF1.mCherry-Actin-9

0020VCT: rLV.EF1.mCherry-Actin-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0021VCT rLV.EF1.mCherry-Tubulin-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Fluorescent labelling of tubulin in mammalian cells

Fluorescent labelling of tubulin in mammalian cells
Fluorescent labelling of tubulin in mammalian cells. HeLa cells were infected at 80 M.O.I. with ready-made lentivirus engineered to expressed AcGFP1-Tubulin (Right image; Cat. No. 0014VCT) or mCherry Tubulin (Left image; Cat. No. 0021VCT).

Back

0021VCT: rLV.EF1.mCherry-Tubulin-9

0021VCT: rLV.EF1.mCherry-Tubulin-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0022VCT rLV.EF1.mCherry-Golgi-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

0022VCT: rLV.EF1.mCherry-Golgi-9

0022VCT: rLV.EF1.mCherry-Golgi-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0023VCT rLV.EF1.mCherry-Nuc-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively)

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively)

The nuclei of HCT116 cells visualized using recombinant lentivirus expressing AcGFP1 or mCherry fluorescent proteins fused to a nuclear localization signal (Cat. Nos. 0016VCT or 0023VCT, respectively).

Back

0023VCT: rLV.EF1.mCherry-Nuc-9

0023VCT: rLV.EF1.mCherry-Nuc-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0024VCT rLV.EF1.mCherry-Mito-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins

Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins
Visualizing mitochondria in mammalian cells using mCherry or AcGFP1 fluorescent proteins. HCT116 cells and Hela cells were transduced using Cat. Nos. 0024VCT and 0017VCT respectively. The lentivirus vectors express a fusion protein consisting of a fluorescent protein tagged with the targeting sequence from subunit VIII of cytochrome c oxidase that targets mitochondria.

Back

0024VCT: rLV.EF1.mCherry-Mito-9

0024VCT: rLV.EF1.mCherry-Mito-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0025VCT rLV.EF1.mCherry-ER-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Fluorescent labelling of endoplasmic reticulum (ER)

Fluorescent labelling of endoplasmic reticulum (ER)
Fluorescent labelling of endoplasmic reticulum (ER). Cells transduced with this premade lentivirus (Cat. No. 0025VCT) will express a fusion protein consisting of mCherry fluorescent protein; the ER targeting sequence of calreticulin, which is fused at the 5' end; and the sequence encoding the ER retrieval sequence, KDEL, which is fused at the 3' end.

Back

0025VCT: rLV.EF1.mCherry-ER-9

0025VCT: rLV.EF1.mCherry-ER-9

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.
0026VCT rLV.EF1.mCherry-Mem-9 3 x 20 uL Inquire for Quotation

License Statement

ID Number  
261 Vectalys’ technology Vectalys’ highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes. Academic and not-for-profit research institutions whose research using the Vectalys’ Technology or the product obtained by the Vectalys’ technology is sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys’ Technology or the product obtained by the Vectalys’ technology. Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com
*

The Flash Therapeutics Constitutive Lentiviral Reporter Vectors are prepackaged lentiviral particles expressing fluorescent protein genes for transducing mammalian cells. The expression of fluorescent protein genes is driven by an EF1α promoter. These VSV-G pseudotyped viruses are capable of infecting both dividing and non-dividing cells. The high purification level of these lentiviral particles allows transduction of primary cells and immortalized cell lines without inducing any toxicity to the cells, even at high multiplicity of infection (M.O.I.).

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components You May Also Like Image Data

Back

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein

Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein
Map schematics of expression cassettes contained in particles for labeling subcellular compartments (e.g. actin, tubulin, mitochondria, etc.) with mCherry red fluorescent protein.

Back

Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane

Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane
Fluorescent images of mammalian cells transduced with either AcGFP1-Mem (left) or mCherry-Mem (right) virus showing clear labeling of the plasma membrane. (Cat. # 0019VCT and 0026VCT, respectively.) The blue channel in the right image is DAPI staining of the nucleus.

Back

0026VCT: rLV.EF1.mCherry-Mem-9

0026VCT: rLV.EF1.mCherry-Mem-9

*You must be logged in to a Purchasing Account in order to purchase these products online, since the purchase of these products may be restricted depending on your account type. Researchers at not-for-profit accounts receive a limited use license with their purchase of the product. Researchers at for-profit accounts must obtain a license prior to purchase. For details please contact licensing@takarabio.com.

Overviews Premade lentiviral particles
Webinars Premade lentivirus webinar
Tips and FAQs Lentiviral particle FAQs

Overview

  • What does 109 TU/ml mean?
    • In each microliter, there will be at least 1 x 106 functional lentivirus particles.
    • Each 60-µl kit is sufficient for 30 transductions (using an MOI of 10) in a 6-well plate containing 2 x 105 cells/well.
  • Ready-to-use particles can be added directly to cells:
    • Highly concentrated lentiviral particles; all lots are >109 transducing units (TU) per ml (functional titer, not a just a particle count).
    • High-purity lentiviral particles—transduce cells without cytotoxicity.
  • Expression can be monitored in living cells by fluorescence microscopy
    • AcGFP1 is a true monomeric green fluorescent protein with spectral properties similar to those of EGFP.
    • mCherry is the most widely adopted monomeric red fluorescent protein.
    • Learn more about the properties of these fluorescent proteins.
  • Particles are available for labeling the nucleus, endoplasmic reticulum, actin, mitochondria, tubulin, endosome, golgi, and plasma membrane.
  • These vectors have a puromycin resistance cassette and the stable clones integrating these constructs can be selected using puromycin.

More Information

Applications

  • Cell organelle/structure labeling—monitor protein localization, protein trafficking, organelle dynamics, etc.
  • Simple method for generating stable reporter cell lines

Additional product information

Please see the product’s Certificate of Analysis for information about storage conditions, product components, and technical specifications. Please see the Kit Components List to determine kit components. Certificates of Analysis and Kit Components Lists are located under the Documents tab.


Watch the webinar to learn about our highly concetrated and purified ready-made lentivirus particles

Webinar: highly concentrated and pure lentiviral particle preps

Watch our webinar to learn all about genome editing with lentiviral particles. Topics covered include: how to produce high-quality and high-titer lentivirus, the differences between lentiviral production systems, and applications such as the use of lentivirus for tet-inducible gene expression or subcellular localization studies.

Webinar Technology overview

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us